New Jersey A 2022: Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.

Status: Introduced in the Assembly, Referred to Assembly Health Committee (as of 2020-01-14)

State: New Jersey · Session: 219 · Bill: A 2022

Subjects: HEALTH INSUR, PHARMACEUTIC

Sponsors: Bramnick, Jon M., Moriarty, Paul D., Vainieri Huttle, Valerie, Caputo, Ralph R., Chaparro, Annette, Dancer, Ronald S., Munoz, Nancy F., Murphy, Carol A.

View New Jersey A 2022 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.